DexCom (DXCM)
(Delayed Data from NSDQ)
$111.94 USD
-0.19 (-0.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $112.03 +0.09 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 161 - 180 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical analysis of 2,543 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices: Diabetes Market Implications from JNJ''s Potential Exit
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 preliminary results missed, guidance light, but G5 gets CMS reimbursement
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
CMS to Reimburse DXCM''s G5; Positive for DXCM, PODD, TNDM; Negative for MDT
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
4Q Results and 2017 Guidance Quell Investor Concerns; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
ACA Uncertainty Creates Buying Opportunity; Previewing 5 Companies Expected to Preannounce Next Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Upcoming Quarters To Be More Unpredictable Due To Competitor Launches, But DXCM To Remain Clear Leader in CGM; Reit. OUTPERFORM; Lowering PT to $100
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 results mixed; ''''law of large numbers'''' and support costs remain a concern
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical analysis of 2,334 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
3Q16 Preview: Stable Growth Trends Through The End of 2016
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Elevated False Alarm Rates With Medtronic''s New Guardian Sensor CGM Could Temper
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
670G Approval Significantly Ahead of Expectations, but Launch Date is in Line; Impact to Competitors to be Minor
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
670G Approval Significantly Ahead of Expectations, but Launch Date is in Line; Impact to Competitors to be Minor
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Diabetes Technology Panel Highlights The Opportunities That Lie Ahead
Provider: WEDBUSH SECURITIES INC.